Daly City, CA, United States of America

Min Xie

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The J. David Gladstone Institutes. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Xie. Retrieved from https://idiyas.com/inventor/min-xie-qijmv2h4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Xie: Innovator in Tauopathy Treatment

Introduction

Min Xie is a notable inventor based in Daly City, CA (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of tauopathies. His innovative approaches aim to address critical health issues related to neurodegenerative diseases.

Latest Patents

Min Xie holds a patent for "Methods for treating tauopathy." This patent outlines methods of reducing the level of acetylated Tau in neurons or glial cells in individuals. The methods involve administering a prodrug that is converted in the individual to salicylate, providing a novel approach to treating tauopathies.

Career Highlights

Min Xie is affiliated with the J. David Gladstone Institutes, where he conducts research focused on neurodegenerative diseases. His work has garnered attention for its potential impact on treatment strategies for conditions that affect cognitive function.

Collaborations

Some of his notable coworkers include Li Gan and Xu Chen, who collaborate with him on various research projects aimed at advancing the understanding and treatment of tauopathies.

Conclusion

Min Xie's contributions to the field of neuroscience, particularly through his patent on tauopathy treatment, highlight his role as an innovator in medical research. His work continues to pave the way for new therapeutic strategies in addressing neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…